Your preferred partner to register and commercialise your product within the UK’s hospital market.
Part of the Mawdsleys group of companies, Lowry Pharma is a young, dynamic company looking to commercialise innovative, orphan and niche generic medicines.
Integrated, seamless and efficient management of all aspects of registration and commercialisation of hospital medicinal products in the UK.
Unique insight and assessment
Lowry Pharma can offer in-depth market analysis due to our unique insight into the NHS, decades of historical sales transaction data and expert critique from our highly esteemed network of Key Opinion Leaders (KOLs) allowing you to create a true picture of your UK opportunity.
Your optimised route to market
A combination of expert in-house and external regulatory consultants select the best regulatory pathway by considering speed to market, cost and likelihood of success.
We match the most appropriately experienced regulatory expert to each product and its submission pathway to ensure maximum efficiency.
Identification of unmet medical need
Managed/Early Access or Named Patient Supply programmes can be implemented if your product meets regulatory requirements.
Through our fully managed and regulated unlicensed team, Lowry can provide a route to market prior to UK registration.
This pre-registration supply can generate revenue and product awareness to KOLs and patient advocacy and collect real world data.
Optimised product launch strategy
Using both in-house and third-party experts, Lowry Pharma aims to deliver a reimbursement and marketing strategy that maximises the value of your medicine.
We combine our well established relationships with payors, UK reimbursement and assessment authorities and clinical KOLs to deliver optimised price and market access.
Established national logistics network
Leveraging Mawdsleys logistic capabilities, Lowry Pharma is able to provide you with a GDP aligned, temperature-controlled delivery service with full traceability and stock and sales visibility.
Daily deliveries into all UK hospitals.
Experienced national sales team
Lowry Pharma will utilise our in-house/contracted sales representatives to support the launch and growth of your product.
The National Health Service (NHS) is UK’s largest consumer of prescription medicines. We’ve been working closely with them for over 50 years, giving us a wealth of knowledge and unique insight and market knowledge.
The Mawdsleys group are the largest independent supplier of hospital medicines to the four NHS regions within the UK.
You will be partnering with a company that really understands and has well established access to the NHS.
The NHS is a complex, multi-layered organisation employing approximately 1.1 million staff (2019), over 1250 hospitals (2019) with 20.5 million hospital admissions per year.
Make sure you partner with a company that really understands and has well established access to the NHS